The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER2 in endometrioid endometrial adenocarcinoma (E-EMCA): Defining incidence, molecular profiles, and outcomes.
 
Shaina F. Bruce
No Relationships to Disclose
 
Sharon Wu
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Alex Farrell
Employment - Caris Life Sciences
 
Matthew James Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Ira Seth Winer
Research Funding - Oncoceutics
 
Britt Kristina Erickson
Research Funding - Clovis Oncology (Inst)
 
Nathaniel L. Jones
No Relationships to Disclose
 
Premal H. Thaker
Stock and Other Ownership Interests - Celsion
Consulting or Advisory Role - AstraZeneca; Celsion; Eisai; GlaxoSmithKline; Immunogen; Iovance Biotherapeutics; Merck; Novocure; Seagen
Research Funding - GlaxoSmithKline (Inst); Merck (Inst)
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline/Tesaro; GOG partners; Roche/Genentech; Seagen; Tesaro
Research Funding - GlaxoSmithKline/Tesaro (Inst)